Neuropsychological sequelae of tamoxifen and exemestane after AC-chemotherapy in postmenopausal women with early breast cancer
C. Schilder(Radboud University Nijmegen), Sanne B. Schagen(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Petronella C. Eggens(The Netherlands Cancer Institute), Willem Boogerd(The Netherlands Cancer Institute), F. S. van Dam(Radboud University Nijmegen)
Cited by 2
Related Papers
Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy
|JNCI Journal of the National Cancer Institute|1998|768
Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial
|Journal of Clinical Oncology|2010|264
Late effects of adjuvant chemotherapy on cognitive function:a follow-up study in breast cancer patients
|Annals of Oncology|2002|260
Modulation of the blood–brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?
|Cancer Treatment Reviews|2004|177